Roche Holding Ltd (ROP/CHF) Stock Price
- Exchange: SIX
- Industry: Drug Manufacturers - General
-
Market Cap
CHF 317.2B -
P/E
23.01 -
Revenue
63B -
EPS (TTM)
CHF 39.1
- Open CHF 391.5
- Low CHF 391.5
- High CHF 391.5
- Prev. Close CHF 389.2
Where to buy Stocks
| Broker | Stocks | ETFs | Account min. |
Safety
|
Users Picked
|
Action |
|---|---|---|---|---|---|---|
|
Stocks
Yes
|
ETFs
Yes
|
Account min.
50
|
Safety
7.1/10
|
Users Picked
1589
|
Action
Trade
Your capital is at risk. |
|
|
Stocks
Yes
|
ETFs
Yes
|
Account min.
2,500
|
Safety
9.2/10
|
Users Picked
952
|
Action
Trade
Your capital is at risk. |
|
|
Stocks
Yes
|
ETFs
Yes
|
Account min.
500
|
Safety
10/10
|
Users Picked
2410
|
Action
Trade
Your capital is at risk. |
Users picked this company on TU in the last 3 months.
Shows the broker`s regulation and safety level based on factors such as tier-1 regulation and investor protection. Learn how we evaluate brokers.
Analyst Consensus
Based on 72 analysts
Your capital is at risk.
- Average Target Price
- CHF 377.2 -3.6%
- Target Price Range
-
CHF 250 Lowest CHF 434.5 Highest
Analyst Consensus is based on aggregated ratings and price targets from analysts covering the stock. The block shows the overall consensus, number of analysts, average target price, and the range between the lowest and highest analyst price targets.
Roche Holding Ltd (ROP) Fundamentals
Key financial metrics
| Revenue | CHF 63B |
|---|---|
| Net Income | CHF 12.3B |
| Free Cash Flow | N/A |
| Operating Margin | 36.2% |
| Net Margin | 19.6% |
| ROE | 38.11% |
ROP/CHF Performance
| Period | Change | Change % |
|---|---|---|
| 1 D | CHF 2.3 | 0.59% |
| 1 W | CHF 20.9 | 5.64% |
| 1 M | CHF 26.9 | 7.38% |
| 3 M | CHF 57.7 | 17.29% |
| 1 Y | CHF 110.7 | 39.42% |
About Roche Holding Ltd
Roche Holding Ltd (ROP) is a healthcare company that develops medicines, diagnostic tests and digital healthcare solutions. Its business combines pharmaceutical research and products with diagnostic technologies used to identify diseases, assess patient risk and help guide treatment. Roche serves patients, healthcare professionals and health systems globally, with activities focused on areas including cancer, cardiovascular-metabolic diseases and neurological diseases.
Investment Return Calculator
FAQs
-
What is the current Roche Holding Ltd (ROP) stock price?
As of Oct 22, 2026, Roche Holding Ltd (ROP) stock is trading at CHF 391.5 CHF.
-
Which stock exchange is Roche Holding Ltd listed on?
Apple is listed on the SIX stock exchange.
-
What is Roche Holding Ltd’s stock ticker symbol?
The stock ticker for Roche Holding Ltd is ROP.
-
What is Roche Holding Ltd’s market capitalization?
Roche Holding Ltd’s current market cap stands at approximately CHF 317.2B.
-
What is Roche Holding Ltd’s earnings per share (EPS)?
Roche Holding Ltd’s trailing twelve-month (TTM) EPS is CHF 39.1.
-
What is the analyst price target for Roche Holding Ltd (ROP)?
The 12-month average price target for Roche Holding Ltd is CHF 377.24, with a high estimate of CHF 434.5 and a low of CHF 250.
-
How volatile is Roche Holding Ltd’s (ROP) stock right now?
During the latest trading session on Oct 22, 2026, Roche Holding Ltd (ROP) moved within a daily range of CHF 391.5-CHF 391.5 and has fluctuated within a 52-week range of CHF 258.2-CHF 391.5.
Latest ROP News
Hansoh Pharmaceutical, Roche strike antibody-drug conjugate deal worth over $15 billion
Roche licenses obesity drug candidate from China’s Rona Therapeutics in deal worth up to $1.16 billion
Alector shares jump as Roche licenses Parkinson's therapy in $1.27 billion deal
Why is Roper Technologies stock up 7.5% today?
Fort Washington stake cut pressures Roper Technologies stock to move down
Disclaimer
All information on the pages containing forecasts, video forecasts, and other analytical materials is published ‘as is’ and for informational purposes only. The information is not intended for trading or advice of financial, investment, tax, legal, accounting or any kind of nature. Before starting to trade, please contact your broker or a financial advisor to check the quotes, evaluate forecasts or the opinion of the author of the article. Our company is not an investment consultant, financial advisor or a broker for transactions involving securities. No information shall be viewed as investment advice, recommendation or offer of our company to buy, hold or sell securities or financial products. Our company does not provide guarantees and does not express opinions about appropriateness or suitability of investments.
No information shall be regarded as investment advice (general or individual). Financial products or transactions mentioned in such information may not be suitable for your investment portfolio and may not meet your investment targets and expectations. You are solely responsible for any decision regarding financial products or transactions and you shall independently determine whether they are suitable for you, taking into account your interests, investment targets, investment horizon and tolerable risk level. Our company shall not bear any responsibility for the losses caused by financial transactions or investments in financial products mentioned on our website. We do not recommend making investment decisions guided solely by this information.
The information on our website is provided by stock exchanges, brokers and other content providers, and, in some cases, may arrive with a delay. Our company does not verify such information and shall waive any liability related to it.
Our company and our information and content providers, financial exchanges, brokers and also all affiliated companies and business partners: a) expressly waive any responsibility for the accuracy, validity and completeness of any data; b) shall not be liable for any mistakes, omissions or other flaws on such information, for delays and interruptions in their display, as well as for actions taken based on such information. Neither our company nor our information providers shall be liable for the damage caused by the use of the information provided here. The term ‘business partners’ in this case shall not imply any partnership or agency relationships as well as the creation of a joint venture between our company and any other organization.
You hereby confirm that you shall not copy, modify, reformat, download, store, reproduce, process, transfer or distribute any information published here or use such information for commercial purposes without prior written consent.
Traders Union as well as its external information and content providers retain exclusive copyright to the provided information.
Our company shall not be liable for the products and services advertised on our website.
General websites Disclaimer:
Traders Union (tradersunion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it. Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Risk disclosure:
Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit.
That is why you should only invest money you are willing and able to lose, given the high level of risk involved. Tradersunion.com does not offer financial services, including investment or financial advisory services. Traders Union is not a broker and does not receive compensation for trading in the Forex or CFD markets. Our website only provides informational content about brokers and financial markets and helps users choose the most suitable brokerage company based on comprehensive data and objective analysis..
Traders Union displays real-time stock prices and market data using third-party providers, primarily Twelve Data and Financial Modeling Prep (FMP). Company fundamentals, earnings data, analyst estimates, price targets, and other market metrics are also sourced from external financial data providers. Providers may be replaced when necessary to ensure continuous market coverage.